ロード中...

The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin

Emerging evidence suggests that dipeptidyl peptidase-4 (DPP-4) inhibitors used to treat type 2 diabetes may have nephroprotective effects beyond the reduced renal risk conferred by glycemic control. DPP-4 is a ubiquitous protein with exopeptidase activity that exists in cell membrane-bound and solub...

詳細記述

保存先:
書誌詳細
出版年:Clin Sci (Lond)
第一著者: Kanasaki, Keizo
フォーマット: Artigo
言語:Inglês
出版事項: Portland Press Ltd. 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828949/
https://ncbi.nlm.nih.gov/pubmed/29491123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/CS20180031
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!